BALTIMORE, May 25, 2011 /PRNewswire/ -- In response to evolving health care guidelines and the needs of its growing membership, XLHealth has reformed its Medical Advisory Board, bringing together nine leading authorities in both clinical program management and medical consulting, who will play a vital role in helping the company formulate new programs and interventions that best serve the needs of its more than 100,000 chronically ill and underserved Medicare members.

The Medical Advisory Board provides knowledge and oversight on clinical issues impacting the various programs under the XLHealth model of care, which supports the health and well being of its health plan members. The board is responsible for assuring that clinical care and recommendations instrumental to the design of the programs are consistent with clinical practice standards.

“The independent contributors appointed to our board provide XLHealth with a deep well of clinical and therapeutic expertise that will ensure our clinical programs are using the most recent research and guidelines to impact member outcomes,” said Henry Meilman, MD, chief medical officer of XLHealth. “Under the guidance of the Medical Advisory Board, we will identify and implement evidence-based improvements to our model of care that will affect our members’ well being in a positive and tangible way.”

Chaired by Dr. Meilman and supported by clinical staff leadership at XLHealth, external members of the company’s newly formed Medical Advisory Board include:

• Wayne Campbell, MD, FACP: Infectious Disease Chief, Chair, Pharmacy & Therapeutics Committee, Co-Chair, MedStar Healthcare Epidemiology and Infection Control Task Force, Associate Program Director, Internal Medicine Residency Program, Union Memorial Hospital
• F. Michael Gloth, III, MD FACP, AGSF, CMD: Associate Professor of Medicine, Division of Geriatric Medicine & Gerontology, Johns Hopkins University School of Medicine, Adjunct Associate Professor of Medicine, Department of Epidemiology and Public Health, University of Maryland School of Medicine, Corporate Medical Director, Mid-Atlantic Health Care
• Christopher Kearney, MD: Chief, Division of Palliative Medicine, Union Memorial Hospital
• Dawn Kershner, DO, MPH, FACC: General Cardiologist, MidAtlantic Cardiovascular Associates
• Paul Sack, MD: Endocrinologist, Division of Diabetes and Endocrinology, Union Memorial Hospital, Clinical Assistant Professor of Medicine, University of Maryland
• Clarence Smith, MD: President, Landmark Medical Group
• Jeffrey L. Tredwell, DPM: Director, Founder, and past Chief Clinical Officer, XLHealth, Founder/Principal, Chronic Disease Specialists - Save a Limb Save a Life
• Kathryn A. Walker, PharmD, BCPS, CPE: Assistant Professor, Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy

“We are honored to have this group of thought leaders and medical practitioners guiding the implementation and evolution of our programs,” said Fred Dunlap, chairman and CEO of XLHealth. “As XLHealth strives to meet the health care needs of the most vulnerable in our society, we are confident that their combined knowledge and leadership will produce further improvements in clinical outcomes for our members.”

About XLHealth Corporation

XLHealth Corporation (http://www.xlhealth.com) is the owner and operator of Care Improvement Plus (http://www.careimprovementplus.com), a Medicare Advantage health plan committed to delivering quality health care benefits and serving the underserved. Focused on improving patient outcomes and reducing health care spending, Care Improvement Plus provides comprehensive Medicare coverage and a Part D prescription drug benefit, plus additional services including care management support.

Contact: Kristi Betz
Office: 410-821-8220
KristiB@imre.com

SOURCE XLHealth Corporation